FIELD: medicine.
SUBSTANCE: composition representing a solid oral dosage form containing 4-Aminopyridine (INN fampridine, USAN dalfampridine), which is an organic compound having chemical formula C5H4N-NH2 as an agent, as well as a substance prolonging release.
EFFECT: improving the composition.
18 cl, 1 dwg, 3 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING DALFAMPRIDIN TABLETS WITH PROLONGED ACTION | 2015 |
|
RU2607655C1 |
| NIACIN-CONTAINING PHARMACEUTICAL COMPOSITION (VERSIONS) AND TABLET PREPARATION, METHOD FOR REDUCING HYPEREMIA AND METHOD FOR PREPARING NIACIN-CONTAINING TABLET | 2007 |
|
RU2467750C2 |
| PROLONGED ACTION PREPARATION OF DICLOFENAC SODIUM | 2002 |
|
RU2221559C1 |
| CONTROLLED-RELEASE PHARMACEUTICAL TABLET FOR ORAL ADMINISTRATION METHODS FOR PREPARATION THEREOF | 2011 |
|
RU2603469C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING IBUPROFEN AND DOMPERIDONE FOR MIGRAINE TREATMENT | 1998 |
|
RU2195935C2 |
| PHARMACEUTICAL COMPOSITION OF METFORMIN WITH PROLONGED RELEASE AND METHOD OF ITS OBTAINING | 2006 |
|
RU2433821C2 |
| PHARMACEUTICAL COMPOSITIONS WITH PROLONGED RELEASE FOR TREATING CEREBROVASCULAR DISORDERS | 2014 |
|
RU2611339C2 |
| MODIFIED RELEASE 6-METHYL-2-ETHYL-HYDROXYPYRIDINE SUCCINATE DOSAGE FORM | 2008 |
|
RU2411035C2 |
| PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
| TWO-LAYERED TABLET FOR PREVENTING CARDIOVASCULAR DISTURBANCES, DRUG AND METHOD FOR PREVENTING CARDIOVASCULAR DISTURBANCES, INCLUDING APOPLEXY AND PARALYSIS BY USING SAID TABLET | 2007 |
|
RU2445088C2 |
